Form 8.3 - Willis Towers Watson plc

LONDON--()-- 

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 13 April 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:

ORD

 

 

Long

Short

Number

(%)

Number

(%)

(1)

Relevant securities

 

 

 

 

1,669,794

1.29%

193,723

0.15%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

102,359

0.08%

7,100

0.01%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,100

0.00%

6,100

0.00%

 

 

 

 

TOTAL:

 

 

 

 

1,778,253

1.38%

206,923

0.16%

 

 

 

 

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale

Number of relevant securities

Price per unit
Purchase

2

242.9800 USD
Purchase

2

244.1900 USD
Purchase

3

243.9166 USD
Purchase

3

242.0966 USD
Purchase

4

242.8600 USD
Purchase

4

242.2400 USD
Purchase

5

241.8100 USD
Purchase

8

243.2387 USD
Purchase

10

244.3500 USD
Purchase

12

241.9416 USD
Purchase

12

242.0633 USD
Purchase

16

241.9825 USD
Purchase

16

242.0200 USD
Purchase

20

241.9720 USD
Purchase

26

241.8600 USD
Purchase

32

241.8607 USD
Purchase

100

244.4550 USD
Purchase

150

243.8932 USD
Purchase

190

241.7821 USD
Purchase

200

242.1550 USD
Purchase

231

242.1612 USD
Purchase

256

241.9700 USD
Purchase

300

241.9833 USD
Purchase

322

242.0796 USD
Purchase

413

241.9839 USD
Purchase

419

242.0391 USD
Purchase

700

241.7878 USD
Purchase

756

241.8545 USD
Purchase

1,105

241.7595 USD
Purchase

1,123

242.4190 USD
Purchase

1,363

243.9407 USD
Purchase

2,100

243.4861 USD
Purchase

2,179

241.8704 USD
Purchase

2,438

243.1335 USD
Purchase

2,729

242.0310 USD
Purchase

2,796

241.9937 USD
Purchase

3,039

242.2833 USD
Purchase

3,522

241.9970 USD
Purchase

4,011

242.1468 USD
Purchase

5,024

242.0500 USD
Purchase

6,876

241.8700 USD
Purchase

7,688

242.0453 USD
Purchase

8,144

242.0005 USD
Purchase

14,494

242.5366 USD
Purchase

17,267

242.1568 USD
Purchase

18,000

242.1316 USD
Sale

5

241.8100 USD
Sale

10

244.3500 USD
Sale

14

242.4350 USD
Sale

33

242.0781 USD
Sale

92

241.9700 USD
Sale

100

242.0800 USD
Sale

150

242.0300 USD
Sale

210

241.9900 USD
Sale

450

242.0976 USD
Sale

488

243.2926 USD
Sale

500

243.2460 USD
Sale

538

243.4557 USD
Sale

700

242.6257 USD
Sale

1,052

242.4930 USD
Sale

1,200

242.6016 USD
Sale

1,208

243.1194 USD
Sale

1,300

243.2792 USD
Sale

1,339

242.7186 USD
Sale

1,588

242.2836 USD
Sale

1,681

241.9415 USD
Sale

1,707

242.5706 USD
Sale

1,841

242.3639 USD
Sale

2,195

241.8803 USD
Sale

2,258

242.1386 USD
Sale

2,285

242.3356 USD
Sale

3,368

242.1174 USD
Sale

3,430

243.6803 USD
Sale

4,139

242.1231 USD
Sale

5,000

242.0500 USD
Sale

6,498

242.0914 USD
Sale

6,876

241.8700 USD
Sale

7,928

241.9565 USD
Sale

9,465

242.2717 USD
Sale

18,462

242.1792 USD
Sale

20,000

242.0070 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure:

14 Apr 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or

Number of

Exercise Type Expiry
purchased

relevant securities

price date

to which the option

or derivative

relates

Put Options Purchased

-100

220.0000

American Jul 16, 2021
Call Options Purchased

100

240.0000

American Jul 16, 2021
Call Options Purchased

6,000

220.0000

American Jul 16, 2021
Put Options Purchased

-6,000

200.0000

American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

Category Code: RET
Sequence Number: 735210
Time of Receipt (offset from UTC): 20210414T120838+0100

Contacts

BARCLAYS PLC

Contacts

BARCLAYS PLC